OTINOVA
LIVE

Serial Number

79343657

Owner

Circius Pharma AB

Attorney

Thomas L Ewing

Filing Date

Feb 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

OTINOVA Trademark

Serial Number: 79343657 • Registration: 7102526

OTINOVA is a trademark filed by Circius Pharma AB on February 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Circius Pharma AB (5 trademarks)

Södra Långebergsgatan 34-36

Entity Type: 16

Trademark Details

Filing Date

February 2, 2022

Registration Date

July 11, 2023

Published for Opposition

April 25, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 6, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 13, 2023 FICS
FINAL DISPOSITION PROCESSED
Oct 13, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 11, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 11, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Apr 25, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 5, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 5, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2023 CNSA
REFUSAL PROCESSED BY IB
Feb 14, 2023 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2023 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 24, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 23, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 15, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 9, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 5, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 5, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 30, 2022 REPR